<code id='52FBAFE58B'></code><style id='52FBAFE58B'></style>
    • <acronym id='52FBAFE58B'></acronym>
      <center id='52FBAFE58B'><center id='52FBAFE58B'><tfoot id='52FBAFE58B'></tfoot></center><abbr id='52FBAFE58B'><dir id='52FBAFE58B'><tfoot id='52FBAFE58B'></tfoot><noframes id='52FBAFE58B'>

    • <optgroup id='52FBAFE58B'><strike id='52FBAFE58B'><sup id='52FBAFE58B'></sup></strike><code id='52FBAFE58B'></code></optgroup>
        1. <b id='52FBAFE58B'><label id='52FBAFE58B'><select id='52FBAFE58B'><dt id='52FBAFE58B'><span id='52FBAFE58B'></span></dt></select></label></b><u id='52FBAFE58B'></u>
          <i id='52FBAFE58B'><strike id='52FBAFE58B'><tt id='52FBAFE58B'><pre id='52FBAFE58B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:79765
          mitochondria
          Illustration of mitochondria, powerhouse of the cell. Adobe

          As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

          A study published this week in Cancer Cell investigated how cancer cells can rob mitochondria from T cells, shutting the immune cell down while energizing themselves. It may be yet another way cancer overcomes both the body’s defenses and resists many immunotherapies like CAR-T therapy and immune checkpoint blockade drugs, experts said.

          advertisement

          “This is a new mechanism of immune evasion. It seems like the cancer cells are draining mitochondria from the T cells,” said Bo Li, a cancer researcher at the University of Pennsylvania and a senior author on the paper. “It’s really amazing. Some of my colleagues, their reaction was like, ‘I can’t believe this is true.’ I understand that. It’s just like the cancer cell is too smart.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Kristina Burow of ARCH Venture Partners shares her next big bets STAT
          Kristina Burow of ARCH Venture Partners shares her next big bets STAT

          AlexHogan/STATKristinaBurowhasawell-trainedeye.That’strueofherworkatARCHVenturePartners,oneofthedrug

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          ALS groups 'won't be played again' by the FDA, drug sponsors

          MattScozzariholdshisgirlfriendSabrinaParker'shandduringafriendshipceremonyinJacksonville,N.C.,inNove